US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

335.54

+27.218.82%

Pre-market: 334.63-0.9100-0.27%04:06 EDT

Volume:457.66K

Turnover:152.18M

Market Cap:712.85M

PE:- -

High:340.20

Open:317.82

Low:317.82

Close:308.33

52wk High:341.93

52wk Low:66.95

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.91

T/O Rate:21.54%

Dividend:1.01

Dividend Rate:0.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

HCA Healthcare (HCA) Is Up 6.1% After Mixed Q2 Beat And Outlook Cut Has The Bull Case Changed?

Simply Wall St.

We Think Sensus Healthcare (NASDAQ:SRTS) Can Afford To Drive Business Growth

Simply Wall St.

Will Rising Analyst Optimism and Efficiency Metrics Change Tenet Healthcare's (THC) Investment Narrative?

Simply Wall St.

Ping An Healthcare And Technology (SEHK:1833) Reported Profits, Is The Stock Fully Priced?

Simply Wall St.

Health Care up as Moderna Leads Biotech Higher - Health Care Roundup

FDA Approves 11 Philip Morris Zyn Ultra Pouches

FDA authorizes 11 ZYN ULTRA products following scientific review

Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop

Health Care Roundup: Market Talk

Worldwide Healthcare Trust Buys Back Shares, Updates Voting Rights

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Brookdale Senior Living (BKD) and Spruce Biosciences (SPRB)

ImmuneOnco Wins FDA Nod to Test Bispecific IMM0306 in Lupus Trial

Press Release: Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement

Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)

UBS Remains a Buy on American Healthcare REIT, Inc. (AHR)

Healthcare Realty Trust (HR) Gets a Hold from UBS

Analysts’ Top Healthcare Picks: Evaxion Biotech (EVAX), Ultragenyx Pharmaceutical (RARE)

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

EC Healthcare shareholders unanimously back AGM resolutions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":335.54,"timestamp":1787688000000,"preClose":308.33,"halted":0,"volume":457661,"hourTrading":{"tag":"盘前","latestPrice":334.63,"preClose":335.54,"latestTime":"04:06 EDT","volume":127,"amount":42553.97255,"timestamp":1787731581148,"change":-0.91,"changeRate":-0.002712,"amplitude":0.00551},"delay":0,"changeRate":0.08824960269840768,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Pre-Mkt","change":27.21,"latestTime":"08-26 04:10:24 EDT","open":317.82,"high":340.1999,"low":317.82,"amount":152177225.23880002,"amplitude":0.072584,"askPrice":341.6,"askSize":200,"bidPrice":328.8,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":335.54,"sharesOutstanding":3074486,"nav":307.714,"aum":638348472.96,"dividendRate":0.003,"bidAskSpread":0.003147,"preHourTrading":{"tag":"盘前","latestPrice":334.63,"preClose":335.54,"latestTime":"04:06 EDT","volume":127,"amount":42553.97255,"timestamp":1787731581148,"change":-0.91,"changeRate":-0.002712,"amplitude":0.00551},"postHourTrading":{"tag":"盘后","latestPrice":335.94,"preClose":335.54,"latestTime":"19:59 EDT","volume":4196,"amount":1407780.9058,"timestamp":1787702372496,"change":0.4,"changeRate":0.001192,"amplitude":0.002801},"volumeRatio":0.9075576628101844,"impliedVol":0.9895,"impliedVolPercentile":0.796},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9075576628101844,"shares":2124486,"dividePrice":1.0066,"high":340.1999,"amplitude":0.072584,"preClose":308.33,"low":317.82,"week52Low":66.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":335.54,"eps":0,"divideRate":0.003,"volume":457661,"delay":0,"ttmEps":0,"open":317.82,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":289.98,"twentyDayClose":242,"sixtyDayClose":195.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661987212","title":"HCA Healthcare (HCA) Is Up 6.1% After Mixed Q2 Beat And Outlook Cut Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661987212","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661987212?lang=en_us&edition=fundamental","pubTime":"2026-08-23 06:16","pubTimestamp":1787437013,"startTime":"0","endTime":"0","summary":"HCA Healthcare recently reported a solid Q2 2026 performance with strong revenue and patient-volume growth, even as it trimmed its full-year outlook to reflect payer and service-mix pressures.\nAlongside plans to present at several upcoming healthcare conferences and continued investment in emergency care capacity, HCA is signaling an emphasis on operational efficiency and technology as it balances growth with reimbursement headwinds.\nNext, we will examine how HCA’s strong quarterly results...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/261825-main-header/1756254640157"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/hca-healthcare-hca-is-up-61-after-mixed-q2-beat-and-outlook","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hca/hca-healthcare/news/hca-healthcare-hca-is-up-61-after-mixed-q2-beat-and-outlook","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","LU0433182093.SGD","HCA","LU1261432733.SGD","LU0128525929.USD","LU0130102774.USD","LU0708994859.HKD","IE00B775SV38.USD","LU0882574055.USD","XBI","LU0985489474.SGD","LU1267930573.SGD","SG9999014039.USD","SG9999014021.USD","LU0203345920.USD","BK4581","IHF","LU0648001328.SGD","LU0187121727.USD","LU2244417387.USD","SG9999014005.SGD","LU0310799852.SGD","LU1267930490.SGD","BK4185","BK4585","LU0029864427.USD","LU0203347892.USD","LU2355687059.USD","SG9999014013.SGD","BK4504","LU0868494617.USD","LU1489326972.SGD","LU0114720955.EUR","LU0211327993.USD","LU0310800379.SGD","LU0980610538.SGD","LU1084165304.USD","XLV","LU0068578508.USD","LU1119994496.HKD","LU1201861249.SGD","IE00B3S45H60.SGD","LU1150488135.SGD","LU1150488218.USD","LU0211328371.USD","LU0878866978.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661219218","title":"We Think Sensus Healthcare (NASDAQ:SRTS) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661219218","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661219218?lang=en_us&edition=fundamental","pubTime":"2026-08-22 22:07","pubTimestamp":1787407674,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-srts/sensus-healthcare/news/we-think-sensus-healthcare-nasdaqsrts-can-afford-to-drive-bu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-srts/sensus-healthcare/news/we-think-sensus-healthcare-nasdaqsrts-can-afford-to-drive-bu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QDTE","IYW","QYLG","TQQQ","NVIW.SI","BK4581","TQQY","LABU","FTEC","XLV","JEPQ",".IXIC","QLD","BK4588","TECS","QQQM","NQmain","ONEQ","SRTS","BK4585","QQQA","SQQQ","QQQY","QQQ","GPIQ","NDX","QID","XBI","MNQmain","BK4082","QQQJ","QQQE","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661821989","title":"Will Rising Analyst Optimism and Efficiency Metrics Change Tenet Healthcare's (THC) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661821989","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661821989?lang=en_us&edition=fundamental","pubTime":"2026-08-22 18:17","pubTimestamp":1787393870,"startTime":"0","endTime":"0","summary":"In recent days, Tenet Healthcare has drawn increased attention from Wall Street as analysts raised their optimism on the company’s earnings prospects, reflected in an average brokerage recommendation that sits between Strong Buy and Buy alongside a top Zacks ranking.\nThis shift in sentiment comes as Tenet Healthcare’s network of hospitals and outpatient facilities has been associated with improving efficiency metrics, including rising free cash flow margins and returns on capital, which many...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/will-rising-analyst-optimism-and-efficiency-metrics-change-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-thc/tenet-healthcare/news/will-rising-analyst-optimism-and-efficiency-metrics-change-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["THC","BK4585","LU0963586101.USD","LU0648000940.SGD","BK4588","BK4581","LU2324357040.USD","THC.AU","XLV","XBI","LU1201861165.SGD","LABU","BK4185","LU0130103400.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661219885","title":"Ping An Healthcare And Technology (SEHK:1833) Reported Profits, Is The Stock Fully Priced?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661219885","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661219885?lang=en_us&edition=fundamental","pubTime":"2026-08-22 17:23","pubTimestamp":1787390617,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology (SEHK:1833) reported half year 2026 earnings with sales of CNY 2,483.83 million and net income of CNY 219.33 million, alongside basic and diluted EPS of CNY 0.10.\nSee our latest analysis for Ping An Healthcare and Technology.\nThe earnings release on 18 August has come after a weak stretch for Ping An Healthcare and Technology, with the share price at HK$6.735 and the year-to-date share price return down 53.81%, while the 3-year total shareholder return is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-reported-profits","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-reported-profits","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4137","JOYT","RGLO","FEBU","BK1615","DCF","LABU","LU0029874061.USD","VGFPF","BK1617","BK1571","LU0128526141.USD","BK4581","XBI","BK1219","BK4585","01833","BK1142","BK1247","VOTE","BK4588","PMDE","HCSG","BK1515","DECU","GXDW","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290104","title":"Health Care up as Moderna Leads Biotech Higher - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290104","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290104?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:19","pubTimestamp":1787347140,"startTime":"0","endTime":"0","summary":"Health-care companies rose as traders rotated into high-risk areas such as biotechnology.Moderna shares rose 9% as a breakthrough in skin-cancer vaccines, divulged earlier this week, continued to stok","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","XBI","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661920582","title":"FDA Approves 11 Philip Morris Zyn Ultra Pouches","url":"https://stock-news.laohu8.com/highlight/detail?id=2661920582","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661920582?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:45","pubTimestamp":1787341500,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration authorized the marketing of 11 of Philip Morris International's Zyn Ultra nicotine pouches, while others remain under review.The FDA approved 10 products with 9-milligram nicotine concentrations and one with an 11-milligram concentration. Other 11-milligram items are under review.In June, the FDA granted modified risk orders for 20 Zyn pouches, allowing the product to carry language that \"Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.\"To date, the FDA has authorized 43 nicotine pouches, including 23 under a pilot program intended to streamline the review process, the agency said Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0426412945.USD","BK4082","BK4588","LU0545562505.USD","LU1043141123.HKD","LOHA","LU0994945656.USD","PMI","LABU","LU0426417589.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661292267","title":"FDA authorizes 11 ZYN ULTRA products following scientific review","url":"https://stock-news.laohu8.com/highlight/detail?id=2661292267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661292267?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:15","pubTimestamp":1787339710,"startTime":"0","endTime":"0","summary":"Philip Morris (PM) International announced that the U.S. Food and Drug Administration issued Marketing Granted Orders to PMI’s U.S. affiliate, Swed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-authorizes-11-zyn-ultra-products-following-scientific-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-authorizes-11-zyn-ultra-products-following-scientific-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0545562505.USD","LU1116320737.USD","VAW","ZYN","IE000M9KFDE8.USD","LU0949170772.SGD","GB00B4QBRK32.GBP","XLP","LU0265550359.USD","BK4566","LU1066051498.USD","LOHA","LU0690374961.EUR","LU2404859741.USD","LU1066051225.USD","RSPM","LU1121112475.USD","LU0265550946.USD","LU1228905540.USD","SG9999001440.SGD","LU2404859667.USD","LU1116320901.HKD","SG9999011175.SGD","PM","LU1043141396.HKD","LU1066053197.SGD","FSTA","UGE","BK4585","FXR","HK0000914660.USD","LU0994945656.USD","NICO","GB00B4LPDJ14.GBP","LU0426412945.USD","LU1066051811.HKD","BK4075","HK0000914686.HKD","LU0738911758.USD","CGDG","LU0661504455.SGD","LU1228905037.USD","TRUO","IYJ","LU1506573853.SGD","LU2381873111.SGD","LU1043141123.HKD","LU0314106906.USD","LU0690374615.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661292264","title":"Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2661292264","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661292264?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:13","pubTimestamp":1787339620,"startTime":"0","endTime":"0","summary":"Replimune Group, Inc. (NASDAQ: REPL) is facing a federal securities lawsuit alleging that investors were not told key facts about regulatory weakne...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-focuses-on-fda-disclosure-issues-and-sharp-repl-stock-drop-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-focuses-on-fda-disclosure-issues-and-sharp-repl-stock-drop-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","BK4139","BK4588","QQQ","SQQQ","TQQY","TQQQ","NQmain","QDTE","NVIW.SI","QYLG","JEPQ",".IXIC","QLD","NDX","LABU","QQQM","GPIQ","BK4585","QQQY","QQQE","TECS","FTEC","QID","IYW","ONEQ","QQQJ","QQQA","MNQmain","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661912122","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2661912122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661912122?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:20","pubTimestamp":1787329200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0540 ET - U.S. stocks linked to cryptocurrencies continue to ris","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0878005551.USD","D05.SI","LU2152927971.USD","BK4581","SG9999001903.USD","LU0169518387.USD","LU0029875118.USD","SG9999005177.SGD","NCIQ","LU0048597586.USD","SG9999002679.SGD","SG9999016042.SGD","XBI","LU0873338254.USD","LU0898667661.SGD","XLV","GDLC","LU0084288322.USD","LU0831093199.SGD","LU1956131251.USD","LU2506952097.USD","SG9999002620.SGD","SG9999000343.SGD","LU1634259391.SGD","LU0532188223.SGD","DAPP","LABU","LU0441851309.USD","SG9999006266.SGD","STCE","LU0061477393.USD","BKCH","LU0823397285.USD","SG9999002562.SGD","LU1504937902.USD","BITW","LU0878004406.USD","LFGY","LU1634259557.SGD","LU2237957811.SGD","LU0384037296.USD","LU1522347837.USD","LU0882747503.HKD","LU1282649141.HKD","BITQ","LU0577902298.EUR","CRPT","LU0261947096.USD","LU0588545490.SGD","BK6516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291218","title":"Worldwide Healthcare Trust Buys Back Shares, Updates Voting Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291218","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291218?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:18","pubTimestamp":1787329109,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) just unveiled an update. Worldwide Healthcare Trust PLC has executed a buyback of 250,000 ordinary...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-buys-back-shares-updates-voting-rights-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-buys-back-shares-updates-voting-rights-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","HCSG","XLV","LABU","XBI","BK4588","BK4585","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661939342","title":"Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2661939342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661939342?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:16","pubTimestamp":1787318162,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF  up 0.1% and the iShares Biotechnology ETF  advancing by 0.6%.Arbutus Biopharma  shares were up more than 9% after the clinical-stage company said it plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at between $5 and $5.75 per share in cash.Aveanna Healthcare Holdings  said selling stockholders priced a secondary public offering of 15 million common shares at $11.75 per share. Aveanna Healthcare stock was down nearly 3% premarket.Werewolf Therapeutics  and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome type 1, the companies said. Shares of Werewolf were up 146% pre-bell.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4196","XLV","LABU","BK4588","HCSG","BK4581","XBI","IBB","BK4585","BK4539","LU0029874061.USD","BK4139","BK4137","HOWL","AVAH","ABUS","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293391","title":"Analysts Offer Insights on Healthcare Companies: Brookdale Senior Living (BKD) and Spruce Biosciences (SPRB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293391?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:50","pubTimestamp":1787316622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Brookdale Senior Living (BKD) and Spruce Biosciences...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brookdale-senior-living-bkd-and-spruce-biosciences-sprb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brookdale-senior-living-bkd-and-spruce-biosciences-sprb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","SPRB","XBI","BK4588","LU1499592464.USD","BK4185","LU0029874061.USD","LU2190626999.HKD","BK4137","BKD","XLV","BK4581","LABU","LU0842063009.USD","BK4585","BK4139","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661173298","title":"ImmuneOnco Wins FDA Nod to Test Bispecific IMM0306 in Lupus Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661173298","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661173298?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:39","pubTimestamp":1787315996,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H ( ($HK:1541) ) has issued an update. ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has secured...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immuneonco-wins-fda-nod-to-test-bispecific-imm0306-in-lupus-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immuneonco-wins-fda-nod-to-test-bispecific-imm0306-in-lupus-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260957","title":"Press Release: Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260957","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260957?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:00","pubTimestamp":1787313600,"startTime":"0","endTime":"0","summary":"-- Proposed merger to create a Nasdaq-listed, late-stage biotechnology. company advancing neridronate, a potential first FDA-approved treatment. for CRPS-1, a debilitating orphan disease with 65,000 newly diagnosed. U.S. patients annually and no currently FDA-approved therapy. -- Pivotal CRPS-RISE Phase 3 trial evaluating neridronate remains ongoing,with FDA Breakthrough Therapy, Fast Track and Orphan Drug designations. received and alignment with FDA that a single successful pivotal trial. -- Neridronate has been administered to approximately 600,000 patients in. -- Concurrent oversubscribed private placement of $150 million from a. syndicate of leading healthcare-dedicated investors expected to fund. company operations through CRPS-RISE Phase 3 topline results and planned","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RISE","BK4139","BK4585","HOWL","BK4588","LABU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260742","title":"Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260742","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260742?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:00","pubTimestamp":1787313600,"startTime":"0","endTime":"0","summary":"ReVeRA-301 Trial is Evaluating the Same 70 mg Repeat-Dose Regimen that is FDA Approved for Paroxysmal Supraventricular Tachycardia (PSVT) Research Builds on Phase 2 Findings that Etripamil 70 mg Dose ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/21/3349033/0/en/milestone-pharmaceuticals-initiates-pivotal-phase-3-trial-of-etripamil-nasal-spray-for-self-administered-treatment-of-atrial-fibrillation-with-rapid-ventricular-rate-afib-rvr.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ECG","FXU","LU0170899867.USD","VR","ED","LU0566484027.USD","BK4129","BK4588","LABU","LU2346227817.USD","BK4208","BK4550","AV","VHT","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260103","title":"UBS Remains a Buy on American Healthcare REIT, Inc. (AHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260103","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260103?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:56","pubTimestamp":1787313371,"startTime":"0","endTime":"0","summary":"UBS analyst Michael Goldsmith maintained a Buy rating on American Healthcare REIT, Inc. today and set a price target of $63.00. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-buy-on-american-healthcare-reit-inc-ahr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-buy-on-american-healthcare-reit-inc-ahr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","XLV","BK4588","IVRA","RJMG","BPRE","RNTY","PSCF","DFRA","XBI","YLDW","BK4585","MDIV","AHR","BK4225","IQRA","REIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260121","title":"Healthcare Realty Trust (HR) Gets a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260121?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:55","pubTimestamp":1787313351,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Goldsmith from UBS maintained a Hold rating on Healthcare Realty Trust, with a price target of $21.00. Goldsmit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/healthcare-realty-trust-hr-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/healthcare-realty-trust-hr-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4203","SRET","BK4581","XLV","HR","XBI","BK4225","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661626792","title":"Analysts’ Top Healthcare Picks: Evaxion Biotech (EVAX), Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661626792","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661626792?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:10","pubTimestamp":1787310632,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evaxion Biotech (EVAX) and Ultragenyx Pharmaceutical...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-evaxion-biotech-evax-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-evaxion-biotech-evax-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","HCSG","XLV","EVAX","LABU","BK4139","BK4588","BK4585","XBI","RARE","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262741","title":"Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262741","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661262741?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:00","pubTimestamp":1787310037,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Corcept Therapeutics (CORT), Alvotech (ALVO) and Abb...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-corcept-therapeutics-cort-alvotech-alvo-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-corcept-therapeutics-cort-alvotech-alvo-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","SGXZ41872573.SGD","LU0211331839.USD","CORT","BK4139","FBT","IE00B2B36J28.USD","LU1559883803.SGD","BK4581","PJP","LU2133065610.SGD","SG9999002232.USD","LU0432979614.USD","LU2237957902.USD","LABU","LU0208291251.USD","LU0868494617.USD","LU0320765489.SGD","LU2324357040.USD","LU2211815571.USD","IHI","IE0009355771.USD","LU2237957811.SGD","LU0058720904.USD","LU1721429741.USD","XLV","ABT","SG9999002224.SGD","BK4568","LU0882574055.USD","HCSG","LU1023059063.AUD","LU1721429402.USD","LU0266013472.USD","BK4082","LU0070302665.USD","LU2112291526.USD","LU0122379950.USD","LU0566484027.USD","LU1914381329.SGD","IE00BFTCPJ56.SGD","PSCH","XBI","BK4137","IE00B4R5TH58.HKD","BK4007","LU0234572021.USD","TMED","ALVO","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661645502","title":"EC Healthcare shareholders unanimously back AGM resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661645502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661645502?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:12","pubTimestamp":1787307163,"startTime":"0","endTime":"0","summary":"An update from EC Healthcare ( ($HK:2138) ) is now available. EC Healthcare has announced that all resolutions put to shareholders at its annual ge...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ec-healthcare-shareholders-unanimously-back-agm-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ec-healthcare-shareholders-unanimously-back-agm-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","LU0029874061.USD","BK4581","LU0128526141.USD","BK4201","BK4137","AGM","BK4229","BK4195","BK4585","EC","XLV","XBI","HCSG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":6,"totalSize":397,"code":"91000000","status":"200"}]}}